No. 25, Kambar Street, Alandur

Product Categories

Diabetology,CNS,Immunology,CVS,Respiratory,Vitamins/Minerals,Dermatology,Anti-Infectives,Anti malarials,Gunaecological,Pain/Analgesics,Sex Stimulants/Rejuventators,Nutraceuticals

Company Profile

Swiss Garnier Life Sciences is part of Swiss Garnier group, is rated amongst the fastest growing pharmaceutical company in India and has won many prestigious awards including the “ Emerging India Award of 2013” which is an bench mark of excellence for India’s SME. Swiss Garnier has developed many products for 1st time in India – Voglibose mouth dissolving tablets , metoprolol ER , Doxophylline range are few to name. Swiss Garnier has initiated radical steps to spear head it’s Global Presence by leveraging on its vast experience, technology and product quality. Swiss Garnier has 3 manufacturing plants at different locations. The plants have WHO-GMP certification and various international approvals. With world class technology and a team of strong professionals, Swiss Garnier possess systems meeting the stringent international manufacturing standards. Expert quality team ensure that systems and processes remain in compliance with the latest standards. Swiss Garnier has finished product formulations in different dosage forms like liquid, tablets, capsules, ointments and powder. Swiss Garnier has recently developed various effervescent formulations. Swiss Garnier product range covers a wide spectrum of therapeutic segments including · Nutraceuticals · Probiotics · Cardio · Anti-ulcer · Antibiotics · Anti histamine · Amino acids · Anti-inflammatory & Antipyretic · Anti- Diabetic · Anti- depressants Swiss Garnier has always strongly believed in creating trusted brands based on quality of its products. This has been possible with infrastructure created by Swiss Garnier. Swiss Garnier is in process of strengthening its field force to intensify its marketing activities. Swiss Garnier pursues its International business through various business modules · Private Market · Tenders / Institution supplies · Contract manufacturing . Joint venture · Distribution Channel · Strategic Alliance Above philosophy and efforts are in Alignment to support the Pharmaceutical division to achieve 100 million USD by 2016. For further details please visit our website “” or email at